SCHEMBL21158613

SCHEMBL21158613

CC(=O)CC(C)(C)NC(=O)CC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.39
HTT P42858 1/20 0.39
ALDH1A1 P00352 1/20 0.36
PIK3CD O00329 1/20 0.36
HPGD P15428 6/20 0.34
KMT2A Q03164 3/20 0.34
RAB9A P51151 3/20 0.34
MEN1 O00255 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C19 P33261 2/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA14 Q9ULX7 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
NPC1 O15118 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19019335 0.82 ALDH1A1 (0.41) SMN1; SMN2ALDH1A1PIK3CDHPGDKMT2A
SCHEMBL17520809 0.81 ALDH1A1 (0.33) ALDH1A1PIK3CDCYP2C19
SCHEMBL21017090 0.79 HPGD (0.48) SMN1; SMN2HTTALDH1A1PIK3CDHPGD
SCHEMBL13328580 0.78 EPHX1 (0.34) SMN1; SMN2HTTALDH1A1PIK3CDGAA
SCHEMBL28154673 0.77 ALDH1A1 (0.41) ALDH1A1L3MBTL1
SCHEMBL5568298 0.76 HMGCR (0.35) ALDH1A1PIK3CDCYP3A4CYP2C19CYP2C9
SCHEMBL15498405 0.76 ALDH1A1 (0.64) SMN1; SMN2HTTALDH1A1PIK3CDHPGD
SCHEMBL13240049 0.76 ALDH1A1 (0.44) SMN1; SMN2HTTALDH1A1PIK3CDHPGD
SCHEMBL1515479 0.75 PIK3CD (0.41) SMN1; SMN2HTTALDH1A1PIK3CDHPGD
SCHEMBL19494993 0.75 ALDH1A1 (0.33) SMN1; SMN2ALDH1A1KMT2AMEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3172211-B1 TRICYCLIC IMIDAZO-PYRIMIDINONE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY LP-PLA2 GLAXOSMITHKLINE IP DEV LTD (GB) 2019-07-03 EP disclosed